FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2607345694> ?p ?o ?g. }

• W2607345694 endingPage "229" @default.
• W2607345694 startingPage "218" @default.
• W2607345694 abstract "Adenosine induces bronchial hyperresponsiveness and inflammation in asthmatics through activation of A2B adenosine receptor (A2BAdoR). Selective antagonists have been shown to attenuate airway reactivity and improve inflammatory conditions in pre-clinical studies. Hence, the identification of novel, potent and selective A2BAdoR antagonist may be beneficial for the potential treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). Towards this effort, we explored several prop-2-ynylated C8-aryl or heteroaryl substitutions on xanthine chemotype and found that 1-prop-2-ynyl-1H-pyrazol-4-yl moiety was better tolerated at the C8 position. Compound 59, exhibited binding affinity (Ki) of 62 nM but was non-selective for A2BAdoR over other AdoRs. Incorporation of substituted phenyl on the terminal acetylene increased the binding affinity (Ki) significantly to <10 nM. Various substitutions on terminal phenyl group and different alkyl substitutions on N-1 and N-3 were explored to improve the potency, selectivity for A2BAdoR and the solubility. In general, compounds with meta-substituted phenyl provided better selectivity for A2BAdoR compared to that of para-substituted analogs. Substitutions such as basic amines like pyrrolidine, piperidine, piperazine or cycloalkyls with polar group were tried on terminal acetylene, keeping in mind the poor solubility of xanthine analogs in general. However, these substitutions led to a decrease in affinity compared to compound 59. Subsequent SAR optimization resulted in identification of compound 46 with high human A2BAdoR affinity (Ki = 13 nM), selectivity against other AdoR subtypes and with good pharmacokinetic properties. It was found to be a potent functional A2BAdoR antagonist with a Ki of 8 nM in cAMP assay in hA2B-HEK293 cells and an IC50 of 107 nM in IL6 assay in NIH-3T3 cells. Docking study was performed to rationalize the observed affinity data. Structure-activity relationship (SAR) studies also led to identification of compound 36 as a potent A2BAdoR antagonist with Ki of 1.8 nM in cAMP assay and good aqueous solubility of 529 μM at neutral pH. Compound 46 was further tested for in vivo efficacy and found to be efficacious in ovalbumin-induced allergic asthma model in mice." @default.
• W2607345694 created "2017-04-28" @default.
• W2607345694 creator A5000670056 @default.
• W2607345694 creator A5004691943 @default.
• W2607345694 creator A5006576666 @default.
• W2607345694 creator A5012534480 @default.
• W2607345694 creator A5019160170 @default.
• W2607345694 creator A5021297919 @default.
• W2607345694 creator A5024537221 @default.
• W2607345694 creator A5025633734 @default.
• W2607345694 creator A5033639689 @default.
• W2607345694 creator A5033787614 @default.
• W2607345694 creator A5048511461 @default.
• W2607345694 creator A5048994298 @default.
• W2607345694 creator A5050723171 @default.
• W2607345694 creator A5053395641 @default.
• W2607345694 creator A5054525881 @default.
• W2607345694 creator A5054933022 @default.
• W2607345694 creator A5056942968 @default.
• W2607345694 creator A5059548549 @default.
• W2607345694 creator A5060134413 @default.
• W2607345694 creator A5067824817 @default.
• W2607345694 creator A5068972659 @default.
• W2607345694 creator A5069157461 @default.
• W2607345694 creator A5070900324 @default.
• W2607345694 creator A5073145785 @default.
• W2607345694 creator A5075779958 @default.
• W2607345694 creator A5083980448 @default.
• W2607345694 creator A5091375000 @default.
• W2607345694 date "2017-07-01" @default.
• W2607345694 modified "2023-09-30" @default.
• W2607345694 title "Design and synthesis of novel xanthine derivatives as potent and selective A 2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases" @default.
• W2607345694 cites W1964654970 @default.
• W2607345694 cites W1968896256 @default.
• W2607345694 cites W1972180267 @default.
• W2607345694 cites W1978777321 @default.
• W2607345694 cites W1988428277 @default.
• W2607345694 cites W1989591424 @default.
• W2607345694 cites W1989813909 @default.
• W2607345694 cites W1991014609 @default.
• W2607345694 cites W1991864133 @default.
• W2607345694 cites W1996409370 @default.
• W2607345694 cites W2002129459 @default.
• W2607345694 cites W2006876214 @default.
• W2607345694 cites W2013999336 @default.
• W2607345694 cites W2014507223 @default.
• W2607345694 cites W2037591811 @default.
• W2607345694 cites W2039399096 @default.
• W2607345694 cites W2042920134 @default.
• W2607345694 cites W2050456292 @default.
• W2607345694 cites W2060625236 @default.
• W2607345694 cites W2060953719 @default.
• W2607345694 cites W2081964154 @default.
• W2607345694 cites W2090580254 @default.
• W2607345694 cites W2095770592 @default.
• W2607345694 cites W2097686380 @default.
• W2607345694 cites W2098414543 @default.
• W2607345694 cites W2100304521 @default.
• W2607345694 cites W2116238347 @default.
• W2607345694 cites W2116418941 @default.
• W2607345694 cites W2117419576 @default.
• W2607345694 cites W2123502006 @default.
• W2607345694 cites W2133710256 @default.
• W2607345694 cites W2138398683 @default.
• W2607345694 cites W2156474349 @default.
• W2607345694 cites W2166844811 @default.
• W2607345694 cites W2171416033 @default.
• W2607345694 cites W2556011302 @default.
• W2607345694 cites W4230825503 @default.
• W2607345694 cites W4250280224 @default.
• W2607345694 doi "https://doi.org/10.1016/j.ejmech.2017.04.014" @default.
• W2607345694 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28415011" @default.
• W2607345694 hasPublicationYear "2017" @default.
• W2607345694 type Work @default.
• W2607345694 sameAs 2607345694 @default.
• W2607345694 citedByCount "28" @default.
• W2607345694 countsByYear W26073456942017 @default.
• W2607345694 countsByYear W26073456942018 @default.
• W2607345694 countsByYear W26073456942019 @default.
• W2607345694 countsByYear W26073456942020 @default.
• W2607345694 countsByYear W26073456942021 @default.
• W2607345694 countsByYear W26073456942022 @default.
• W2607345694 countsByYear W26073456942023 @default.
• W2607345694 crossrefType "journal-article" @default.
• W2607345694 hasAuthorship W2607345694A5000670056 @default.
• W2607345694 hasAuthorship W2607345694A5004691943 @default.
• W2607345694 hasAuthorship W2607345694A5006576666 @default.
• W2607345694 hasAuthorship W2607345694A5012534480 @default.
• W2607345694 hasAuthorship W2607345694A5019160170 @default.
• W2607345694 hasAuthorship W2607345694A5021297919 @default.
• W2607345694 hasAuthorship W2607345694A5024537221 @default.
• W2607345694 hasAuthorship W2607345694A5025633734 @default.
• W2607345694 hasAuthorship W2607345694A5033639689 @default.
• W2607345694 hasAuthorship W2607345694A5033787614 @default.
• W2607345694 hasAuthorship W2607345694A5048511461 @default.
• W2607345694 hasAuthorship W2607345694A5048994298 @default.
• W2607345694 hasAuthorship W2607345694A5050723171 @default.
• W2607345694 hasAuthorship W2607345694A5053395641 @default.

• next